Source link : https://newshealth.biz/health-news/nirsevimab-might-top-maternal-vax-for-infants-rsv-protection/
(MedPage Today) — Infants given the monoclonal antibody nirsevimab (Beyfortus) to provide passive immunity against respiratory syncytial virus (RSV) had a lower rate of related hospitalizations and severe outcomes than those whose mothers got… Source link : https://www.medpagetoday.com/pediatrics/rsv/119142 Author : Publish date : 2025-12-22 20:50:00 Copyright for syndicated content belongs to the linked Source.
The post Nirsevimab Might Top Maternal Vax for Infants’ RSV Protection first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-22 20:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8